Skip to main content

Sanctura FDA Approval History

FDA Approved: Yes (Discontinued) (First approved May 28, 2004)
Brand name: Sanctura
Generic name: trospium chloride
Dosage form: Tablets
Company: Allergan plc
Treatment for: Urinary Frequency, Urinary Incontinence, Overactive Bladder

Marketing Status: Discontinued

Sanctura (trospium chloride) is an antispasmodic, antimuscarinic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Development timeline for Sanctura

Aug  6, 2007Approval Indevus Announces FDA Approval of Sanctura XR
May 28, 2004Approval Sanctura Indevus Pharmaceuticals, Inc. - Treatment for Overactive Bladder

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.